ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.46B
Enterprise Value2.65B
P/E Ratio132.74
PEG Ratio-2.54
Price/Sales Ratio2.65
Price/Book Ratio4.92
Enterprise/Revenue2.94
Enterprise/EBITDA16.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.06

Income Statement

Revenue870.79M
Revenue/Share3.54
Gross Profit586.75M
EBITDA171.79M
Net Income24.85M
Diluted EPS0.1

Balance Sheet

Total Cash137.61M
Total Cash/Share0.56
Total Debt393.16M
Total Debt/Equity0.89
Current Ratio0.98
Book Value Per Share2.11

Price History

52-Week Change-25.88
52-Week High15.2
52-Week Low6.93
Moving Average 50 Days8.43
Moving Average 200 Days10.67

Statistics

Average Volume14.29M
Shares Outstanding257.21M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.74
Last Split Factor6:5
Last Split DateJuly 08, 2016
AD